Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412866 · ClinicalTrials.gov registry record · NA
Electronic Decision Support Systems for Smokers With Severe Mental Illness
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT01412866: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT01412866 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 124 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01412866, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This randomized clinical trial among SMI smokers assessed whether the EDSS with carbon monoxide monitor and health-checklist feedback lead to higher rates of initiation of smoking cessation treatment, days of smoking abstinence and Fagerstrom Dependence scores, compared to use of the EDSS with checklist feedback alone.
Primary Outcome
Started smoking cessation treatment
Interventions
- BEHAVIORAL EDSS with CO feedback and health checklist
- BEHAVIORAL EDSS with health checklist feedback alon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT01412866 record still lists
NCT01412866 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which EDSS with CO feedback and health checklist is the first listed.
NCT01412866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01412866 about?
NCT01412866 is a clinical study titled "Electronic Decision Support Systems for Smokers With Severe Mental Illness". This randomized clinical trial among SMI smokers assessed whether the EDSS with carbon monoxide monitor and health-checklist feedback lead to higher rates of initiation of smoking cessation treatment, days of smoking abstinence and Fagerstrom Dependence scores, compared to use of the EDSS with check...
What is the current status of trial NCT01412866?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01412866?
The interventions under investigation include: EDSS with CO feedback and health checklist (BEHAVIORAL), EDSS with health checklist feedback alon (BEHAVIORAL).
Who is sponsoring clinical trial NCT01412866?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01412866's enrollment target sits among peer trials
124 758th of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia